Sign in
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Endolaserless Vitrectomy with Intravitreal Aflibercept
Dennis M. Marcus, MD
Updates from the Field
2017
Correlation Of Ganglion Cell Layer Damage And Diabetic Macular Ischemia Using OCT Angiography and Their Relationship With Visual Acuity in Diabetes
Dilraj S Grewal, MD, FASRS
On Demand Cases, Courses, and Papers
Category: Diabetic Retinopathy